LU88574I2 - CEFEPIME et ses sels pharmaceutiquement acceptables (Maxipime R) - Google Patents

CEFEPIME et ses sels pharmaceutiquement acceptables (Maxipime R)

Info

Publication number
LU88574I2
LU88574I2 LU88574C LU88574C LU88574I2 LU 88574 I2 LU88574 I2 LU 88574I2 LU 88574 C LU88574 C LU 88574C LU 88574 C LU88574 C LU 88574C LU 88574 I2 LU88574 I2 LU 88574I2
Authority
LU
Luxembourg
Prior art keywords
maxipime
cefepime
pharmaceutically acceptable
acceptable salts
salts
Prior art date
Application number
LU88574C
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of LU88574I2 publication Critical patent/LU88574I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
LU88574C 1985-08-05 1986-08-04 CEFEPIME et ses sels pharmaceutiquement acceptables (Maxipime R) LU88574I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05

Publications (1)

Publication Number Publication Date
LU88574I2 true LU88574I2 (fr) 1995-03-01

Family

ID=25064475

Family Applications (2)

Application Number Title Priority Date Filing Date
LU86540A LU86540A1 (fr) 1985-08-05 1986-08-04 Sels de cephalosporine et compositions injectables
LU88574C LU88574I2 (fr) 1985-08-05 1986-08-04 CEFEPIME et ses sels pharmaceutiquement acceptables (Maxipime R)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LU86540A LU86540A1 (fr) 1985-08-05 1986-08-04 Sels de cephalosporine et compositions injectables

Country Status (34)

Country Link
JP (1) JPH0615548B2 (pt)
KR (1) KR930003121B1 (pt)
AR (1) AR243894A1 (pt)
AT (1) AT390957B (pt)
AU (1) AU597262B2 (pt)
BE (1) BE905219A (pt)
CA (1) CA1284994C (pt)
CH (1) CH675581A5 (pt)
CS (2) CS276717B6 (pt)
CY (1) CY1614A (pt)
DD (2) DD254941A5 (pt)
DE (1) DE3626375A1 (pt)
DK (1) DK162053C (pt)
EG (1) EG18003A (pt)
ES (1) ES2002112A6 (pt)
FI (1) FI84484C (pt)
FR (1) FR2585705B1 (pt)
GB (1) GB2179936B (pt)
GR (1) GR862055B (pt)
HK (1) HK99691A (pt)
HU (1) HU196602B (pt)
IE (1) IE59222B1 (pt)
IL (1) IL79608A (pt)
IT (1) IT1197067B (pt)
LU (2) LU86540A1 (pt)
MY (1) MY102212A (pt)
NL (1) NL8601991A (pt)
OA (1) OA08672A (pt)
PT (1) PT83134B (pt)
SE (1) SE469633B (pt)
SG (1) SG79791G (pt)
SU (1) SU1516013A3 (pt)
YU (1) YU45793B (pt)
ZA (1) ZA865842B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
KR950010084B1 (ko) * 1987-06-25 1995-09-06 반유세이야꾸 가부시끼가이샤 결정성 세팔로스포린 화합물, 그의 제조법 및 그의 제조 중간체
JPH02101081A (ja) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd セファロスポリン誘導体結晶性二塩酸塩及びその製造法
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
EP0638573A1 (en) * 1993-08-10 1995-02-15 Lucky Ltd. Crystalline hydrates of cephalosporin and process for preparation thereof
ES2298850T3 (es) 2003-12-23 2008-05-16 Sandoz Gmbh Proceso para la produccion de intermedios para utilizar en la sintesis de la cefalosporina.
WO2008056221A2 (en) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Crystalline sulfate salt of cephalosporin antibiotic
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
FI863155A0 (fi) 1986-08-01
DE3626375A1 (de) 1987-02-12
JPS62103090A (ja) 1987-05-13
FI84484C (fi) 1991-12-10
CS276717B6 (en) 1992-08-12
EG18003A (en) 1991-08-30
HU196602B (en) 1988-12-28
DD268395A5 (de) 1989-05-31
SE8603308D0 (sv) 1986-08-04
GB2179936B (en) 1989-04-26
PT83134B (pt) 1989-07-31
GR862055B (en) 1986-12-24
ATA211086A (de) 1990-01-15
YU137186A (en) 1987-12-31
JPH0615548B2 (ja) 1994-03-02
KR880002530A (ko) 1988-05-09
FR2585705A1 (fr) 1987-02-06
YU45793B (sh) 1992-07-20
CA1284994C (en) 1991-06-18
AR243894A1 (es) 1993-09-30
PT83134A (en) 1986-09-01
IT8621409A1 (it) 1988-02-04
FI84484B (fi) 1991-08-30
NL8601991A (nl) 1987-03-02
IE862078L (en) 1987-02-05
FR2585705B1 (fr) 1989-01-13
HUT41802A (en) 1987-05-28
GB2179936A (en) 1987-03-18
ES2002112A6 (es) 1988-07-16
IL79608A (en) 1991-07-18
GB8618989D0 (en) 1986-09-17
AT390957B (de) 1990-07-25
HK99691A (en) 1991-12-13
IE59222B1 (en) 1994-01-26
BE905219A (fr) 1987-02-04
SU1516013A3 (ru) 1989-10-15
CS276849B6 (en) 1992-08-12
DK162053C (da) 1992-02-10
IT8621409A0 (it) 1986-08-04
KR930003121B1 (ko) 1993-04-19
SE8603308L (sv) 1987-02-06
DK371886D0 (da) 1986-08-04
DK162053B (da) 1991-09-09
OA08672A (en) 1989-03-31
ZA865842B (en) 1987-04-29
CY1614A (en) 1992-07-10
IT1197067B (it) 1988-11-25
SG79791G (en) 1991-11-15
AU6069486A (en) 1987-02-12
SE469633B (sv) 1993-08-09
IL79608A0 (en) 1986-11-30
MY102212A (en) 1992-05-15
CH675581A5 (pt) 1990-10-15
DK371886A (da) 1987-02-06
AU597262B2 (en) 1990-05-31
DD254941A5 (de) 1988-03-16
LU86540A1 (fr) 1987-03-06
FI863155A (fi) 1987-02-06

Similar Documents

Publication Publication Date Title
LU88576I2 (fr) RISPERIDONE et ses sels pharmaceutiquement acceptables (Risperdal R)
LU90484I2 (fr) Novorapid - insuline asparte et ses sels et derives pharmaceutiquement acceptables
LU90069I2 (fr) Lercanidipine et ses sels et dérivés pharmaceutiquement acceptables (Zanidip)
LU90829I2 (fr) Tepoxalin-zubrin et ses d-riv-s pharmaceutiquement acceptables
DE10199054I2 (de) Hypoglycenisches Agens
LU91072I2 (fr) Eplerenone et ses sels pharmaceutiquement acceptables - INSPRA
NZ215024A (en) Peptidase inhibitors
DK394586A (da) Fungicidt aktive propenoatderivater
DK346486A (da) Aminosalicylsyrederivater og farmaceutiske midler
IT1204303B (it) Fresa
LU88574I2 (fr) CEFEPIME et ses sels pharmaceutiquement acceptables (Maxipime R)
LU88843I2 (fr) Ropivacaine et ses dérivés pharmaceutiquement acceptables (Naropine R)
DK349586A (da) Enzyminhibitor
DK139286A (da) Inden- og naphthalenderivater
MC1729A1 (fr) Sels polycycliques
GR862032B (en) Dopamine-b-hydroxylase inhibitors
ZA868269B (en) Dipamine-beta-hydroxylase inhibitors
DK518085D0 (da) Slaglemoelle
DK172486D0 (da) Heterocyclyl-penem-forbindelser samt deres fremstilling og anvendelse
IT1200125B (it) Composti di cefalosporina e procedimento per produrli
PT87198A (pt) Moinho de martelos
IT1200094B (it) Derivato di isochinolina e suoi sali terapeuticamente accettabili
DK206686A (da) Acylaminomethyl-penem-forbindelser samt deres fremstilling og anvendelse
DK418886D0 (da) Hammermoelle
GR860362B (en) Dopamine -b-hydroxylase inhibitors